+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Customized Peptide Synthesis Service Market by Application, Product Type, Synthesis Type, End User - Global Forecast to 2030- Product Image
Customized Peptide Synthesis Service Market by Application, Product Type, Synthesis Type, End User - Global Forecast to 2030- Product Image
Sale

Customized Peptide Synthesis Service Market by Application, Product Type, Synthesis Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079959
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unlocking the Promise of Customized Peptide Synthesis

Peptide synthesis stands at the forefront of scientific innovation, driving breakthroughs across drug discovery, diagnostics, and advanced research applications. As the demand for bespoke peptides continues to surge, organizations require nuanced insights to navigate an increasingly complex landscape. This report offers an authoritative exploration of the customized peptide synthesis market, delineating technological advances, regulatory shifts, and competitive dynamics that shape strategic decision-making.

By synthesizing the latest data and industry perspectives, we provide an essential guide for stakeholders aiming to optimize investment, streamline operations, and capitalize on emerging opportunities. Our objective is to equip executives, researchers, and business development leaders with the foresight needed to stay ahead in a market defined by rapid evolution and high stakes.

Technological Evolution Redefining Peptide Synthesis

The customized peptide synthesis arena has undergone a profound transformation, fueled by rapid technological progress and evolving customer demands. Solid phase synthesis has achieved remarkable efficiencies through refined Fmoc and Boc chemistries, while liquid phase approaches have expanded coupling strategies to enhance yield and purity. Innovations in peptidomimetics and cyclic peptide constructs now enable the design of molecules with superior stability and target specificity, addressing challenges in drug delivery and therapeutic efficacy.

Concurrently, the integration of automation and high-throughput platforms has reduced cycle times and minimized human error, allowing for scalable production of labeled, specialty, and standard peptides. Advanced purification techniques, including multi-dimensional chromatography, further elevate product quality. As academic research, pharmaceutical developers, and diagnostic companies demand bespoke solutions, service providers are pivoting toward end-to-end offerings that encompass synthesis, characterization, and regulatory support. Together, these shifts are redefining the standards of customization and driving a new era of peptide innovation.

Navigating the Financial Headwinds of 2025 Tariffs

The imposition of new United States tariffs in 2025 has introduced a significant variable to the economics of peptide synthesis. Higher duty rates on imported raw materials, including specialized amino acid derivatives and coupling reagents, have elevated input costs for contract synthesis providers. Organizations that rely on global supply chains must now contend with increased lead times and budgetary pressures, prompting a reassessment of sourcing strategies and inventory planning.

In response, some market participants are accelerating the shift toward domestic procurement and localized production to mitigate customs expenses and currency fluctuations. This has led to strategic partnerships with regional suppliers capable of offering competitive pricing and consistent quality. Manufacturers are also investing in process intensification-optimizing reaction conditions and reducing solvent usage-to offset cost escalations. The cumulative impact of these tariffs underscores the importance of agile procurement frameworks and robust risk management to maintain profitability and supply continuity.

Deciphering Market Dynamics Through Segmentation

A nuanced understanding of market segmentation illuminates the diverse demands shaping peptide synthesis services. By application, the sector spans academic research endeavors that focus on basic discovery, functional analysis, and protein interaction studies; cosmetic formulations aimed at anti-aging solutions, hair care innovations, and skin repair therapies; diagnostic ventures targeting biomarker detection and in vitro diagnostics; food and beverage safety testing and nutraceutical development; and pharmaceutical and biotechnology operations encompassing clinical diagnostics, drug discovery, and preclinical research.

Delineating product types reveals three primary categories: labeled peptides, which include biotin-, fluorescent-, and isotope-tagged constructs; specialty peptides such as cyclic sequences, modified variants featuring amidation, glycosylation or phosphorylation, and novel peptidomimetics; and standard peptides available in long, medium, and short chain formats. Synthesis modalities bifurcate into liquid phase approaches, predominantly solution phase coupling, and solid phase techniques utilizing both Boc and Fmoc chemistries. End users range from academic institutions and contract research organizations to cosmetic producers, diagnostic laboratories, food and beverage enterprises, and pharmaceutical and biotech companies. These intersecting layers of application, product type, synthesis method, and end user drive tailored service offerings and inform strategic investment decisions.

Unveiling Regional Growth Levers in Peptide Synthesis

Regional perspectives underscore the global footprint and growth potential of customized peptide synthesis. In the Americas, demand is concentrated in North America’s robust biotech clusters, with heavy academic and pharmaceutical activity driving high-value contract synthesis projects. Latin American markets are emerging, propelled by government initiatives to expand local R&D infrastructure and partnerships with multinational firms.

Within Europe, Middle East & Africa, Western Europe maintains a leadership position through established life science hubs, whereas the Middle East and Africa are witnessing nascent investment in synthetic biology and diagnostic capabilities. Collaborative grants and public-private partnerships are accelerating market entry in these regions. Meanwhile, Asia-Pacific exhibits the fastest growth trajectory, fueled by significant increases in R&D spend across China, Japan, South Korea, and India. Localized manufacturing capacities and favorable regulatory reforms further enhance the region’s appeal for both global service providers and indigenous startups.

Profiling Key Innovators and Market Drivers

Leading players in customized peptide synthesis are consolidating their positions through strategic acquisitions, capacity expansions, and technology partnerships. Established contract research organizations are broadening their service portfolios to include advanced labeling, complex modifications, and integrated analytical platforms, thereby catering to end-to-end project needs. Meanwhile, niche specialists are differentiating through proprietary chemistries, such as next-generation cyclization techniques and novel linker technologies that enhance peptide stability and bioavailability.

Collaborations between peptide synthesis companies and instrumentation providers are also shaping the competitive landscape by enabling real-time monitoring and rapid quality control. Furthermore, key industry actors are investing in sustainability initiatives, optimizing solvent recycling and reducing waste streams to align with environmental mandates. This convergence of operational excellence, innovation pipelines, and strategic alliances underscores the pivotal role of industry leaders in driving market maturation and unlocking new value propositions for customers.

Strategic Imperatives for Sustained Market Leadership

Industry leaders must adopt a proactive posture to capitalize on the dynamic peptide synthesis landscape. First, integrating adaptive sourcing strategies will mitigate the financial impact of trade policies; blending local procurement with strategic stockpiling ensures supply resilience. Second, investing in automation and modular platform technologies will streamline workflows, reduce turnaround times, and enhance reproducibility. Third, fostering cross-sector collaborations-connecting academic researchers, cosmetic formulators, and pharmaceutical developers-can generate novel application pathways and co-development opportunities.

Leaders should also prioritize sustainability by implementing green chemistry principles, recycling solvents, and exploring flow-based synthesis to minimize environmental impact. Finally, cultivating talent through ongoing training in advanced peptide chemistries and analytical techniques will safeguard quality standards and drive continuous innovation. These actionable measures will position organizations to navigate market headwinds, meet evolving customer requirements, and sustain long-term growth in an increasingly competitive environment.

Comprehensive Approach to Market Research

This report synthesizes information from a comprehensive research framework that combines primary and secondary data sources. Primary research included in-depth interviews with industry executives, service providers, end users, and subject matter experts to capture current operational challenges, technology preferences, and procurement behaviors. Secondary research drew on peer-reviewed journals, patent filings, regulatory filings, and company disclosures to verify technological advancements and competitive developments.

Market segmentation schemas were validated through cross-referencing multiple data points, ensuring that application, product type, synthesis method, and end user categories reflect real-world business models. Regional insights were triangulated using government databases, trade associations, and in-market visits. Quantitative data were analyzed with robust statistical techniques to identify interdependencies and trend trajectories, while qualitative insights provided context and foresight. This rigorous methodology underpins the report’s reliability and equips stakeholders with actionable intelligence.

Synthesis of Insights for Strategic Growth

Customized peptide synthesis represents both a scientific frontier and a market opportunity defined by rapid innovation and complex value chains. From advanced labeling applications to high-throughput therapeutic constructs, peptide technologies are reshaping research methodologies and treatment paradigms across industries. However, navigating regulatory shifts, geopolitical tensions, and evolving customer expectations requires informed decision-making and strategic agility.

By integrating detailed segmentation analyses, regional assessments, and competitive profiles, this report delivers a holistic view of the market’s drivers and constraints. As organizations seek to harness the full potential of peptides, the insights provided here will serve as a roadmap for investment prioritization, operational optimization, and technology adoption. Ultimately, this executive summary highlights the critical levers that will propel the peptide synthesis market forward and foster sustained innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Academic Research
      • Basic Research
      • Functional Analysis
      • Protein Interaction Studies
    • Cosmetic
      • Anti Aging
      • Hair Care
      • Skin Repair
    • Diagnostic
      • Biomarker Detection
      • In Vitro Diagnostics
    • Food And Beverage
      • Food Safety Testing
      • Nutraceuticals
    • Pharmaceutical And Biotechnology
      • Clinical Diagnostics
      • Drug Discovery
      • Preclinical Research
  • Product Type
    • Labeled Peptides
      • Biotin Labels
      • Fluorescent Labels
      • Isotope Labels
    • Specialty Peptides
      • Cyclic Peptides
      • Modified Peptides
        • Amidation
        • Glycosylation
        • Phosphorylation
      • Peptidomimetics
    • Standard Peptides
      • Long Peptides
      • Medium Peptides
      • Short Peptides
  • Synthesis Type
    • Liquid Phase Synthesis
      • Solution Phase Coupling
    • Solid Phase Synthesis
      • Boc Chemistry
      • Fmoc Chemistry
  • End User
    • Academic Institutions
    • Contract Research Organizations
    • Cosmetic Companies
    • Diagnostic Laboratories
    • Food And Beverage Companies
    • Pharmaceutical And Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Bachem Holding AG
  • GenScript Biotech Corporation
  • PolyPeptide Group SA
  • CPC Scientific Inc.
  • AmbioPharm Inc.
  • Advanced Automated Peptide Protein Technologies, Inc.
  • Shanghai Peptide Biotech Co., Ltd.
  • Creative Peptides LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Customized Peptide Synthesis Service Market, by Application
8.1. Introduction
8.2. Academic Research
8.2.1. Basic Research
8.2.2. Functional Analysis
8.2.3. Protein Interaction Studies
8.3. Cosmetic
8.3.1. Anti Aging
8.3.2. Hair Care
8.3.3. Skin Repair
8.4. Diagnostic
8.4.1. Biomarker Detection
8.4.2. In Vitro Diagnostics
8.5. Food And Beverage
8.5.1. Food Safety Testing
8.5.2. Nutraceuticals
8.6. Pharmaceutical And Biotechnology
8.6.1. Clinical Diagnostics
8.6.2. Drug Discovery
8.6.3. Preclinical Research
9. Customized Peptide Synthesis Service Market, by Product Type
9.1. Introduction
9.2. Labeled Peptides
9.2.1. Biotin Labels
9.2.2. Fluorescent Labels
9.2.3. Isotope Labels
9.3. Specialty Peptides
9.3.1. Cyclic Peptides
9.3.2. Modified Peptides
9.3.2.1. Amidation
9.3.2.2. Glycosylation
9.3.2.3. Phosphorylation
9.3.3. Peptidomimetics
9.4. Standard Peptides
9.4.1. Long Peptides
9.4.2. Medium Peptides
9.4.3. Short Peptides
10. Customized Peptide Synthesis Service Market, by Synthesis Type
10.1. Introduction
10.2. Liquid Phase Synthesis
10.2.1. Solution Phase Coupling
10.3. Solid Phase Synthesis
10.3.1. Boc Chemistry
10.3.2. Fmoc Chemistry
11. Customized Peptide Synthesis Service Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Contract Research Organizations
11.4. Cosmetic Companies
11.5. Diagnostic Laboratories
11.6. Food And Beverage Companies
11.7. Pharmaceutical And Biotechnology Companies
12. Americas Customized Peptide Synthesis Service Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Customized Peptide Synthesis Service Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Customized Peptide Synthesis Service Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Lonza Group AG
15.3.3. Bachem Holding AG
15.3.4. GenScript Biotech Corporation
15.3.5. PolyPeptide Group SA
15.3.6. CPC Scientific Inc.
15.3.7. AmbioPharm Inc.
15.3.8. Advanced Automated Peptide Protein Technologies, Inc.
15.3.9. Shanghai Peptide Biotech Co., Ltd.
15.3.10. Creative Peptides LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET MULTI-CURRENCY
FIGURE 2. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET MULTI-LANGUAGE
FIGURE 3. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FUNCTIONAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PROTEIN INTERACTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ANTI AGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SKIN REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY BIOMARKER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY BIOTIN LABELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FLUORESCENT LABELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ISOTOPE LABELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY AMIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY GLYCOSYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHOSPHORYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LONG PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MEDIUM PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SHORT PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLUTION PHASE COUPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 99. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 100. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 101. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 102. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 105. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 106. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 107. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 108. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 110. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 111. CANADA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 191. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 192. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 200. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 205. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 206. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 207. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 212. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 215. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 235. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 236. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 237. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 238. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 241. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 242. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 243. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 244. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 245. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 246. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 247. ITALY CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 250. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 251. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 252. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 256. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 257. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 258. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 259. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LABELED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SPECIALTY PEPTIDES, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY MODIFIED PEPTIDES, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY STANDARD PEPTIDES, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA CUSTOMIZED PEPTIDE SYNTHESIS SERVICE MARKET SIZE, BY COSMETI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Customized Peptide Synthesis Service market report include:
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Bachem Holding AG
  • GenScript Biotech Corporation
  • PolyPeptide Group SA
  • CPC Scientific Inc.
  • AmbioPharm Inc.
  • Advanced Automated Peptide Protein Technologies, Inc.
  • Shanghai Peptide Biotech Co., Ltd.
  • Creative Peptides LLC

Related Topics

Related Reports

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast to 2030 - Product Image

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Peptide Synthesis Market Size, Share and Trends Analysis Report by Product (Equipment, Reagents & Consumables), Application (Therapeutics, Diagnosis), Technology, End-use, and Region 2024-2030 - Product Image

Peptide Synthesis Market Size, Share and Trends Analysis Report by Product (Equipment, Reagents & Consumables), Application (Therapeutics, Diagnosis), Technology, End-use, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029 - Product Image

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

  • Report
  • 564 Pages
  • Global
From
Peptide Synthesis Market Report 2025 - Product Image

Peptide Synthesis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Peptide Synthesis - Global Strategic Business Report - Product Image

Peptide Synthesis - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.